FMR LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.02 and the average weighting 0.7%.

Quarter-by-quarter ownership
FMR LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$873,882
-12.4%
68,701
-3.0%
0.00%
Q2 2023$997,488
-52.9%
70,844
-48.4%
0.00%
Q1 2023$2,119,596
+63.4%
137,190
+73.3%
0.00%
Q4 2022$1,297,455
-10.5%
79,161
+1.0%
0.00%
Q3 2022$1,450,000
+25.9%
78,375
-10.6%
0.00%
Q2 2022$1,152,000
+43.5%
87,638
+1.3%
0.00%
Q1 2022$803,000
+3915.0%
86,536
+4226.8%
0.00%
Q4 2021$20,000
-99.9%
2,000
-99.5%
0.00%
-100.0%
Q3 2021$13,876,000
-7.2%
408,354
-0.0%
0.00%0.0%
Q2 2021$14,950,000
-58.3%
408,367
-49.0%
0.00%
-66.7%
Q1 2021$35,892,000
-56.6%
800,457
-44.7%
0.00%
-57.1%
Q4 2020$82,661,000
+38.5%
1,448,402
+24.5%
0.01%
+16.7%
Q3 2020$59,680,000
+23.2%
1,163,356
+43.4%
0.01%
+20.0%
Q2 2020$48,456,000
+22.6%
811,400
-15.5%
0.01%0.0%
Q1 2020$39,530,000
-30.3%
960,153
+5.4%
0.01%
-16.7%
Q4 2019$56,677,000
+994.4%
910,631
+496.8%
0.01%
+500.0%
Q3 2019$5,179,000
+322.4%
152,589
+180.7%
0.00%
Q2 2019$1,226,000
-64.2%
54,367
-63.2%
0.00%
Q1 2019$3,426,000
+10.4%
147,578
-0.2%
0.00%
Q4 2018$3,104,000
-91.5%
147,880
-84.2%
0.00%
-100.0%
Q3 2018$36,354,000
-21.8%
938,886
-20.6%
0.00%
-20.0%
Q2 2018$46,515,000
+162.1%
1,182,091
+33.5%
0.01%
+150.0%
Q1 2018$17,746,000885,5200.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,086,723$85,910,00025.70%
SV Health Investors, LLC 449,951$18,525,00015.54%
Redmile Group, LLC 5,116,263$210,637,0005.90%
Eversept Partners, LP 414,081$17,047,7154.24%
Sunesis Advisors, LLC 96,299$3,965,0003.99%
Avoro Capital Advisors LLC 2,000,000$82,340,0002.78%
Opaleye Management Inc. 222,000$9,140,0002.42%
SECTORAL ASSET MANAGEMENT INC 204,059$8,401,0001.61%
Artal Group S.A. 800,000$32,936,0001.39%
Atika Capital Management LLC 141,000$5,805,0001.11%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders